Joel Greenblatt’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $44.3M | Buy |
200,586
+67,879
| +51% | +$18.8M | 0.1% | 236 |
|
|
2026
Q1 | $39.2M | Sell |
132,707
-9,988
| -7% | -$2.97M | 0.12% | 190 |
|
|
2025
Q4 | $39M | Sell |
142,695
-30,541
| -18% | -$8.3M | 0.14% | 133 |
|
|
2025
Q3 | $46.8M | Buy |
173,236
+50,402
| +41% | +$13.7M | 0.2% | 41 |
|
|
2025
Q2 | $33.9M | Buy |
122,834
+32,629
| +36% | +$8.87M | 0.2% | 47 |
|
|
2025
Q1 | $23.9M | Buy |
90,205
+4,228
| +5% | +$1.04M | 0.2% | 57 |
|
|
2024
Q4 | $20M | Buy |
85,977
+7,209
| +9% | +$1.66M | 0.19% | 82 |
|
|
2024
Q3 | $17.4M | Sell |
78,768
-22,654
| -22% | -$4.69M | 0.18% | 90 |
|
|
2024
Q2 | $19.9M | Buy |
101,422
+56,554
| +126% | +$11.7M | 0.26% | 31 |
|
|
2024
Q1 | $9.66M | Buy |
44,868
+13,891
| +45% | +$2.92M | 0.15% | 149 |
|
|
2023
Q4 | $6.52M | Buy |
30,977
+12,679
| +69% | +$2.71M | 0.12% | 205 |
|
|
2023
Q3 | $3.66M | Sell |
18,298
-2,866
| -14% | -$570K | 0.08% | 370 |
|
|
2023
Q2 | $3.92M | Sell |
21,164
-18,987
| -47% | -$3.51M | 0.09% | 319 |
|
|
2023
Q1 | $7.69M | Buy |
40,151
+13,341
| +50% | +$2.41M | 0.19% | 93 |
|
|
2022
Q4 | $4.51M | Buy |
26,810
+20,073
| +298% | +$3.49M | 0.13% | 188 |
|
|
2022
Q3 | $1.19M | Sell |
6,737
-6,295
| -48% | -$1.24M | 0.04% | 591 |
|
|
2022
Q2 | $2.67M | Sell |
13,032
-9,427
| -42% | -$2M | 0.09% | 291 |
|
|
2022
Q1 | $5.34M | Buy |
22,459
+17,344
| +339% | +$4.07M | 0.17% | 156 |
|
|
2021
Q4 | $1.17M | Sell |
5,115
-4,018
| -44% | -$884K | 0.04% | 499 |
|
|
2021
Q3 | $1.77M | Buy |
9,133
+6,616
| +263% | +$1.34M | 0.07% | 333 |
|
|
2021
Q2 | $535K | Buy |
+2,517
| New | +$531K | 0.02% | 662 |
|
|
2020
Q4 | – | Sell |
-2,664
| Closed | -$446K | – | 1011 |
|
|
2020
Q3 | $446K | Buy |
2,664
+411
| +18% | +$69.2K | 0.01% | 757 |
|
|
2020
Q2 | $366K | Sell |
2,253
-4,161
| -65% | -$746K | 0.01% | 818 |
|
|
2020
Q1 | $1.11M | Buy |
6,414
+3,923
| +157% | +$781K | 0.03% | 524 |
|
|
2019
Q4 | $500K | Buy |
+2,491
| New | +$511K | 0.01% | 812 |
|
|
2019
Q2 | – | Sell |
-9,279
| Closed | -$1.53M | – | 1149 |
|
|
2019
Q1 | $1.53M | Buy |
9,279
+1,613
| +21% | +$285K | 0.02% | 544 |
|
|
2018
Q4 | $1.44M | Sell |
7,666
-4,726
| -38% | -$873K | 0.02% | 564 |
|
|
2018
Q3 | $2.11M | Sell |
12,392
-56,119
| -82% | -$9.45M | 0.03% | 484 |
|
|
2018
Q2 | $11.2M | Buy |
68,511
+61,196
| +837% | +$10M | 0.16% | 202 |
|
|
2018
Q1 | $1.18M | Buy |
+7,315
| New | +$1.16M | 0.02% | 586 |
|
|
2017
Q3 | – | Sell |
-37,922
| Closed | -$4.75M | – | 928 |
|
|
2017
Q2 | $4.75M | Buy |
37,922
+19,217
| +103% | +$2.3M | 0.07% | 369 |
|
|
2017
Q1 | $2.22M | Buy |
18,705
+11,487
| +159% | +$1.38M | 0.03% | 536 |
|
|
2016
Q4 | $833K | Sell |
7,218
-10,932
| -60% | -$1.22M | 0.01% | 655 |
|
|
2016
Q3 | $1.9M | Buy |
18,150
+10,014
| +123% | +$1.05M | 0.02% | 504 |
|
|
2016
Q2 | $792K | Buy |
+8,136
| New | +$769K | 0.01% | 660 |
|
|
2015
Q3 | – | Sell |
-20,798
| Closed | -$1.94M | – | 925 |
|
|
2015
Q2 | $1.94M | Buy |
+20,798
| New | +$1.94M | 0.02% | 556 |
|
|
2014
Q3 | – | Sell |
-4,716
| Closed | -$335K | – | 996 |
|
|
2014
Q2 | $335K | Buy |
+4,716
| New | +$332K | ﹤0.01% | 860 |
|
Other funds holding CME
Joel Greenblatt's CME Position: Q2 2026 in Review
Joel Greenblatt increased its CME Group (CME) stake by 51% in Q2 2026, buying an estimated $18.8M and bringing the position to 200,586 shares worth $44.3M. The position accounts for 0.1% of the portfolio, ranked #236.
Joel Greenblatt first reported a position in CME in Q2 2014 and has held it in 37 quarters since. The position peaked at $46.8M in Q3 2025. 1,694 funds tracked by Wall St. Rank hold CME as of Q2 2026.
- Joel Greenblatt held 200,586 shares of CME Group worth $44.3M as of Q2 2026.
- Joel Greenblatt bought 67,879 CME Group shares in Q2 2026, an estimated $18.8M.
- CME Group made up 0.1% of Joel Greenblatt's portfolio in Q2 2026, its #236 holding.
- Joel Greenblatt first reported a position in CME Group in Q2 2014 and has held it in 37 quarters since.
- Joel Greenblatt's CME Group position peaked at $46.8M in Q3 2025.
- 1,694 funds tracked by Wall St. Rank held CME Group as of Q2 2026.
Based on Gotham Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.